Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program

BACKGROUND: Cryptococcal antigen (CrAg) screening and treatment with preemptive fluconazole reduces the incidence of clinically evident cryptococcal meningitis in individuals living with advanced human immunodeficiency virus (HIV) disease. However, mortality remains higher in CrAg-positive than in C...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Wake, Rachel M, Govender, Nelesh P, Omar, Tanvier, Nel, Carolina, Mazanderani, Ahmad Haeri, Karat, Aaron S, Ismail, Nazir A, Tiemessen, Caroline T, Jarvis, Joseph N, Harrison, Thomas S
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Articles and Commentaries
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7346756/
https://ncbi.nlm.nih.gov/pubmed/31179488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz485
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars